<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">ARSci</journal-id><journal-title-group><journal-title>Advances in Reproductive Sciences</journal-title></journal-title-group><issn pub-type="epub">2330-0744</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/arsci.2023.114011</article-id><article-id pub-id-type="publisher-id">ARSci-128359</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Evaluation of Glutathione Peroxidase Enzymatic Activity in Seminal Plasma of Patients Treated at the Institute Pasteur in Cote d’Ivoire
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Marie</surname><given-names>Florence N’Guessan</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Bi</surname><given-names>Bali Sery</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Foua</surname><given-names>Jonas Vanié Bi</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>N’Gbesso</surname><given-names>Amos Ekissi</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Youzan</surname><given-names>Ferdinand Djohan</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Founzégué</surname><given-names>Amadou Coulibaly</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Allico</surname><given-names>Joseph Djaman</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Biochemistry Unit, Physiology of Reproductive Cells, Institute Pasteur in Ivory Coast, Abidjan, Cote d’Ivoire</addr-line></aff><aff id="aff4"><addr-line>Laboratory of Biotechnology Agriculture and Valorization of Biological Resources, Departement Biosciences, University Félix Hou-phouet-Boigny, Abidjan, Cote d’Ivoire</addr-line></aff><aff id="aff3"><addr-line>Medical Sciences Training and Research Unit, Department of Basic and Bioclinical Sciences, Abidjan, Felix Houphouet-Boigny Uni-versity, Abidjan, Cote d’Ivoire</addr-line></aff><aff id="aff5"><addr-line>Agriculture, Fishery Resources and Agro-Industry Training and Research Unit, University of San-Pedro, San-Pedro, 
Cote d’Ivoire</addr-line></aff><aff id="aff2"><addr-line>The Laboratory of The Medical Sciences Training and Research Unit, Felix Houphouet-Boigny University, Abidjan, Cote d’Ivoire</addr-line></aff><pub-date pub-type="epub"><day>01</day><month>09</month><year>2023</year></pub-date><volume>11</volume><issue>04</issue><fpage>116</fpage><lpage>126</lpage><history><date date-type="received"><day>20,</day>	<month>July</month>	<year>2023</year></date><date date-type="rev-recd"><day>10,</day>	<month>September</month>	<year>2023</year>	</date><date date-type="accepted"><day>18,</day>	<month>October</month>	<year>2023</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Glutathione peroxidase (GPx) is an antioxidant that plays an important role in the maintenance of male fertility. 
  The aim of this study was to compare the profile of enzymatic activity of glutathione peroxidase in the seminal plasma of normozoosperm and those of pathological sperm. Thus, the activity of glutathione peroxidase was determined in the seminal plasma of 20 
  normozoosperms, 9 azoosperms and 31 oligoasthenoteratozoosperms. It was 37.58 &#177; 3.14 U/L in normozoosperms, 39.39 &#177; 2.27 U/L in oligoasthenoteratozoosperms, and 29.77 &#177; 2.62 U/L in azoosperms. The mean GPx enzyme activity of normozoosperms did not differ significantly from that of oligoasthenoteratozoosperms and azoosperms. In contrast, comparison of enzyme activity between abnormal sperms gave a significant difference. This study showed that glutathione peroxidase enzymatic activity is not related to sperm quality.
 
</p></abstract><kwd-group><kwd>Glutathione Peroxidase</kwd><kwd> Antioxidant</kwd><kwd> Oligoasthenoteratozoospermia</kwd><kwd>  Azoospermia</kwd><kwd> Normozoospermia</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Seminal plasma provides nutrition, protection, mobility and survival of spermatozoa [<xref ref-type="bibr" rid="scirp.128359-ref1">1</xref>] . This medium has been the subject of numerous biochemical investigations due to its complex composition and its important role in male fertility [<xref ref-type="bibr" rid="scirp.128359-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.128359-ref3">3</xref>] . It is considered to be the biological fluid that contains the greatest amount and variety of antioxidants [<xref ref-type="bibr" rid="scirp.128359-ref4">4</xref>] . These are involved in the protection of spermatozoa. Reactive oxygen species (ROS) are also present in semen. They can have both beneficial and detrimental effects on sperm. They are essential for sperm survival, integrity and fertilization. The balance between ROS production and sperm antioxidants is a key determinant of sperm homeostasis [<xref ref-type="bibr" rid="scirp.128359-ref4">4</xref>] . Oxidative stress is characterized by an imbalance between ROS production and cellular antioxidant capacity. The ROS in excess in sperm are responsible for cellular damage leading to infertility [<xref ref-type="bibr" rid="scirp.128359-ref5">5</xref>] . In semen, antioxidants prevent or slow oxidative stress by neutralizing ROS [<xref ref-type="bibr" rid="scirp.128359-ref4">4</xref>] . Glutathione peroxidase (GPx) is a seleno-protein enzyme with an enzyme function. Several GPx are present in seminal plasma and on spermatozoa [<xref ref-type="bibr" rid="scirp.128359-ref6">6</xref>] . Some genes encoding GPx are differentially expressed in the male genital tract. Failure of expression of these genes is correlated with male infertility [<xref ref-type="bibr" rid="scirp.128359-ref7">7</xref>] . Several authors have shown the important role of GPx inhibitor in human sperm lipid peroxidation in vitro [<xref ref-type="bibr" rid="scirp.128359-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.128359-ref9">9</xref>] . In addition to its role as an antioxidant, it regulates the process of sperm DNA compaction [<xref ref-type="bibr" rid="scirp.128359-ref10">10</xref>] .</p><p>Thus, GPx plays an important role in the maintenance of male fertility. Also, can characterization of GPx in seminal plasma improve the diagnosis and medical management of male infertility? It appears important to evaluate the activity of GPx in seminal plasma in order to better understand its action in the latter. Therefore, the aim of this study is to evaluate the enzymatic activity of glutathione peroxidase in the seminal plasma of men with different fertility potentials.</p></sec><sec id="s2"><title>2. Material and Methods</title><sec id="s2_1"><title>2.1. Biological Materials</title><p>This study involved the analysis of human semen samples. These were collected from voluntary patients who came to Institute Pasteur in Cote d’Ivoire for a biological exploration of fertility and who respected the three-day abstinence period.</p></sec><sec id="s2_2"><title>2.2. Methods</title><p>Thus, 60 semen samples were selected for this study: 20 normozoosperms, 9 azozoosperms and 31 oligoasthenoteratozoosperms.</p><sec id="s2_2_1"><title>2.2.1. Spermogram Realization</title><p>The spermogram was carried out in accordance with the instructions of the World Health Organization reference manual for semen analysis, sixth edition [<xref ref-type="bibr" rid="scirp.128359-ref11">11</xref>] .</p></sec><sec id="s2_2_2"><title>2.2.2. Seminal Plasma Collection</title><p>After cytological analysis of the semen, the remaining semen was centrifuged at 3000 rpm for 10 min. The seminal plasma was collected and stored at −20˚C until the day of analysis.</p></sec><sec id="s2_2_3"><title>2.2.3. Determination of GPx Enzymatic Activity</title><p>The enzymatic activity of glutathione peroxidase was determined in seminal plasma by the spectrophotometric method described by Paglia and Valentine using the RANSEL&#174; kit (RANDOX Laboratories, Ltd.) [<xref ref-type="bibr" rid="scirp.128359-ref12">12</xref>] . The absorbance is measured at 340 nm. This method is based on the following principle: GPx catalyzes the oxidation of reduced glutathione (GSH) to cumene hydroperoxide in the presence of glutathione reductase (GR) and NADPH. In the presence of glutathione reductase, oxidized glutathione (GSH) is immediately converted to the reduced form with the oxidation of NADPH to NADP<sup>+</sup>. GPx activity was expressed as units per liter.</p></sec></sec><sec id="s2_3"><title>2.3. Ethical Consideration</title><p>Sperm samples were collected with written consent of the patients, and the study was approved by the National Ethics Committee for Life Sciences and Health (CNESVS), Order No. 036-13/CNESVS. The study was conducted in accordance with the legal and regulatory provisions of the Helsinki Law Statement.</p></sec><sec id="s2_4"><title>2.4. Statistical Analysis</title><p>Graph Pad Prism 7 software and Excel (2013) were used for statistical analysis of the different data obtained. The results were reported as mean &#177; standard deviation. Comparisons between seminal plasma enzyme activities of azoosperms, teratozoosperm oligoasthenosperms, and normozoosperms were made using Mann-Whitney tests for unpaired samples. A 95% confidence interval was used. A P value &lt; 0.05 was considered statistically significant.</p></sec></sec><sec id="s3"><title>3. Results</title><p>The distribution of the different categories of semen according to age groups showed a low number of azoospermia in all age groups (<xref ref-type="fig" rid="fig1">Figure 1</xref>). While the number of oligoasthenoteratozoosperms was high in all age groups except that for years. The average age of the different categories of sperm was 39.95 &#177; 1.29 years in normozoosperms. For oligoasthenoteratospermic and azoospermic sperm, the average age was 39 &#177; 1.23 and 37.78 &#177; 2.16 years, respectively (<xref ref-type="table" rid="table1">Table 1</xref>). There was no significant difference between the ages of the patients in the different sperm categories.</p><p><xref ref-type="table" rid="table1">Table 1</xref> shows the characteristics of the three types of semen. The mean volume was 2.90 &#177; 0.22 mL in normozoospermic patients, 2.869 &#177; 0.23 mL in oligoasthenoteratozoospermic patients, and that of azoosperms which was 2.4 &#177; 0.42 mL. The mean sperm concentration of normozoosperms was 66.1 &#177; 9.96 million, and 4.31 &#177; 0.73 million sperm in oligoasthenoteratozoospermia. The</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Profile of the different categories of semen</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Param&#232;tres</th><th align="center" valign="middle"  colspan="3"  >Patients</th><th align="center" valign="middle"  colspan="6"  >P-value</th></tr></thead><tr><td align="center" valign="middle" >NOR (n = 20)</td><td align="center" valign="middle" >OAT (n = 31)</td><td align="center" valign="middle" >AZO (n = 9)</td><td align="center" valign="middle"  colspan="2"  >NOR &amp; OAT</td><td align="center" valign="middle"  colspan="2"  >NOR &amp; AZO</td><td align="center" valign="middle"  colspan="2"  >OAT &amp; AZO</td></tr><tr><td align="center" valign="middle" >years</td><td align="center" valign="middle" >39.95 &#177; 1.29</td><td align="center" valign="middle" >39.13 &#177; 1.23</td><td align="center" valign="middle" >37.78 &#177; 2.16</td><td align="center" valign="middle" >0.65</td><td align="center" valign="middle" >NS</td><td align="center" valign="middle" >0.3742</td><td align="center" valign="middle" >NS</td><td align="center" valign="middle" >0.6005</td><td align="center" valign="middle" >NS</td></tr><tr><td align="center" valign="middle" >Vol (mL)</td><td align="center" valign="middle" >2.905 &#177; 0.22</td><td align="center" valign="middle" >2.869 &#177; 0.23</td><td align="center" valign="middle" >2.4 &#177; 0.42</td><td align="center" valign="middle" >0.91</td><td align="center" valign="middle" >NS</td><td align="center" valign="middle" >0.2498</td><td align="center" valign="middle" >NS</td><td align="center" valign="middle" >0.3344</td><td align="center" valign="middle" >NS</td></tr><tr><td align="center" valign="middle" >pH</td><td align="center" valign="middle" >7.75 &#177; 0.06</td><td align="center" valign="middle" >7.76 &#177; 0.05</td><td align="center" valign="middle" >7.81 &#177; 0.09</td><td align="center" valign="middle" >0.91</td><td align="center" valign="middle" >NS</td><td align="center" valign="middle" >0.5662</td><td align="center" valign="middle" >NS</td><td align="center" valign="middle" >0.6003</td><td align="center" valign="middle" >NS</td></tr><tr><td align="center" valign="middle" >Num. 10<sup>6</sup></td><td align="center" valign="middle" >66.1 &#177; 9.96</td><td align="center" valign="middle" >4.31 &#177; 0.73</td><td align="center" valign="middle" >0.00 &#177; 0.00</td><td align="center" valign="middle" >&lt;0.0001</td><td align="center" valign="middle" >****</td><td align="center" valign="middle" >0.0001</td><td align="center" valign="middle" >***</td><td align="center" valign="middle" >0.0031</td><td align="center" valign="middle" >**</td></tr><tr><td align="center" valign="middle" >Morp</td><td align="center" valign="middle" >8.65 &#177; 0.84</td><td align="center" valign="middle" >1.1 &#177; 0.22</td><td align="center" valign="middle" >0.00 &#177; 0.00</td><td align="center" valign="middle" >&lt;0.0001</td><td align="center" valign="middle" >****</td><td align="center" valign="middle" >&lt;0.0001</td><td align="center" valign="middle" >****</td><td align="center" valign="middle" >0.0128</td><td align="center" valign="middle" >*</td></tr><tr><td align="center" valign="middle" >Vit (%)</td><td align="center" valign="middle" >74.4 &#177; 2.21</td><td align="center" valign="middle" >68 &#177; 2.22</td><td align="center" valign="middle" >0.00 &#177; 0.00</td><td align="center" valign="middle" >0.036</td><td align="center" valign="middle" >*</td><td align="center" valign="middle" >&lt;0.0001</td><td align="center" valign="middle" >****</td><td align="center" valign="middle" >&lt;0.0001</td><td align="center" valign="middle" >****</td></tr><tr><td align="center" valign="middle" >Mob (%) (a + b + c)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >1<sup>st</sup> hour</td><td align="center" valign="middle" >53 &#177; 1.72</td><td align="center" valign="middle" >27.9 &#177; 2.22</td><td align="center" valign="middle" >0.00 &#177; 0.00</td><td align="center" valign="middle" >&lt;0.0001</td><td align="center" valign="middle" >****</td><td align="center" valign="middle" >&lt;0.0001</td><td align="center" valign="middle" >****</td><td align="center" valign="middle" >&lt;0.0001</td><td align="center" valign="middle" >****</td></tr><tr><td align="center" valign="middle" >4<sup>th</sup> hour</td><td align="center" valign="middle" >38.25 &#177; 1.63</td><td align="center" valign="middle" >11.45 &#177; 1.25</td><td align="center" valign="middle" >0.00 &#177; 0.00</td><td align="center" valign="middle" >&lt;0.0001</td><td align="center" valign="middle" >****</td><td align="center" valign="middle" >&lt;0.0001</td><td align="center" valign="middle" >****</td><td align="center" valign="middle" >&lt;0.0001</td><td align="center" valign="middle" >****</td></tr></tbody></table></table-wrap><p>P &lt; 0.05: Significant difference. Num: numeration. Mob: Mobility. * weakly significant. Morp: Morphology. Vit: Vitality. ** moderately significant. *** very significant. **** highly significant. NS: not significant. N: number of samples. Nor: normozoosperms. OAT: oligoasthenoteratozoosperms. AZO: azoosperms.</p><p>mean pH measured in the samples was 7.75 &#177; 0.06 for normozoospermia, 7.76 &#177; 0.05 for oligoasthenoteratozoospermia, and 7.81 &#177; 0.09 for azoospermia, respectively. The average of typical forms of sperm was 8.65% &#177; 0.84% for normozoosperms. In contrast, it was 1.1 &#177; 0.22 in oligoasthenoteratozoosperms. The average vitality of normal spermatozoa observed was 74.40% &#177; 2.21% and 68% &#177; 2.22% for oligoasthenoteratozoospermic. The mean motility of normozoosperm observed at 1st hour was 53% &#177; 1.72% and 38.25% &#177; 1.63% at fourth hour. In oligoasthenoteratozoospermia, it was 27.9% &#177; 2.22% at first hour and 11.45% &#177; 1.25% at fourth hour.</p><p>Results from normozoosperms gave a mean GPx concentration of 37.58 &#177; 3.14 U/L. As for oligoasthenoteratozoospermic samples, the mean GPx concentration was 39.39 &#177; 2.27 U/L and that of the azospermic samples was 29.77 &#177; 2.62 U/L. The mean GPx enzyme activity in normozoosperms did not differ greatly from that in oligoasthenoteratozoosperms, of which it was slightly lower (<xref ref-type="fig" rid="fig2">Figure 2</xref>). In azoosperms, GPx enzyme activity was lower than in normozoosperms but did not differ significantly (<xref ref-type="fig" rid="fig3">Figure 3</xref>). Comparison of enzyme activity between abnormal sperm yielded a significant P-value (<xref ref-type="fig" rid="fig4">Figure 4</xref>).</p></sec><sec id="s4"><title>4. Discussion</title><p>Age influences semen quality in men. Endocrine changes, morphological and functional alternations of the aging testis, lead to a decrease in testosterone production [<xref ref-type="bibr" rid="scirp.128359-ref13">13</xref>] . Increasing age leads to a decrease in sperm function and furthermore male fertility [<xref ref-type="bibr" rid="scirp.128359-ref14">14</xref>] . It affects semen parameters such as volume, motility and sperm morphology [<xref ref-type="bibr" rid="scirp.128359-ref15">15</xref>] . Also our study showed that the mean age of normozoosperms was approximately equal to those of semens azoospermic and oligoasthenoteratozoospermic. The P-value showed no significant difference between the subjects of the study. Therefore, the characteristics of the different sperms analyzed were not related to age. Batou et al. showed that the average age of men consulting for infertility in Libreville (GABON) was 39.5 &#177; 7.9 years; which is roughly equal to the average age of the patients selected for this study. This age range corresponds to the period when the desire for procreation becomes a concern for couples [<xref ref-type="bibr" rid="scirp.128359-ref16">16</xref>] .</p><p>Most studies suggest that increasing paternal age has negative effects on fertility and presents some genetic risk to offspring. It is also important to note that advanced paternal age appears to be associated with an increased risk of spontaneous abortion in women and an increased frequency of certain autosomal dominant conditions, autism spectrum disorders and schizophrenia in children [<xref ref-type="bibr" rid="scirp.128359-ref17">17</xref>] . But the age at which this decline in male fertility appears and the features of it are poorly defined [<xref ref-type="bibr" rid="scirp.128359-ref14">14</xref>] .</p><p>Volume, vitality, concentration, motility, and morphology are the essential criteria for semen characterization [<xref ref-type="bibr" rid="scirp.128359-ref11">11</xref>] . Semen volume is a function of annexing gland secretions, permeability of the reproductive tract and smooth muscle contraction [<xref ref-type="bibr" rid="scirp.128359-ref18">18</xref>] . Volumes of the different categories of semen did not show any significant difference. Indeed, all sperm selected for the study showed normal volume.</p><p>Sperm count is an important parameter of sperm. On the way to the egg, many sperm are lost or die naturally. Thus, the passage through the vagina, the cervix and the arrival at the egg through the fallopian tubes constitute a real obstacle course in which many sperm do not reach their destination [<xref ref-type="bibr" rid="scirp.128359-ref19">19</xref>] . Also, the WHO has set the sperm count of normal semen at fifteen million [<xref ref-type="bibr" rid="scirp.128359-ref11">11</xref>] . Male infertility secondary to oligozoospermia is surprisingly common. Although some cases are idiopathic, oligozoospermia can be caused by endocrine dysfunction, anatomical abnormalities, medications, or environmental exposures [<xref ref-type="bibr" rid="scirp.128359-ref20">20</xref>] . Azoospermia, which is an absence of sperm in the semen, has several etiologies. These fall into three general categories: pre-testicular, testicular and post-testicular. Pre-testicular causes of azoospermia are endocrine abnormalities that adversely affect spermatogenesis. Testicular etiologies involve intrinsic disorders of spermatogenesis within the testes. Post-testicular causes of azoospermia include obstruction of the ductal system at any location in the male reproductive system [<xref ref-type="bibr" rid="scirp.128359-ref21">21</xref>] .</p><p>Sperm vitality was normal for normozoospermic and oligoasthenoteratozoospermic sperm selected for this study. The causes of necrozoospermia are numerous. They can be infectious, or linked to seminal plasma abnormalities (problem of viscosity, collection, prostatovesicular markers, prolonged abstinence, etc.), epididymal abnormalities (disturbance of epididymal markers), testicular pathologies, the presence of anti-sperm antibodies (cytotoxic) and the existence of general or local hyperthermia [<xref ref-type="bibr" rid="scirp.128359-ref22">22</xref>] .</p><p>Sperm motility is reduced in oligoasthenoteratozoospermia. Asthenozoospermia corresponds to reduced or absent mobility sperm in the ejaculate. It is one of the main causes of male infertility. This condition can result from structural defects of the sperm flagellum related to genetic factors or the presence of sperm antibodies, excessive use of alcohol, tobacco, marijuana and other drugs. Other factors include age, fever, exposure to toxic agents such as fertilizers and chemical solvents, infections, poor diet, prolonged exposure to heat, oncological treatments such as chemotherapy and radiation, and varicoceles, which can lead to decreased sperm motility [<xref ref-type="bibr" rid="scirp.128359-ref23">23</xref>] .</p><p>Sperm formation is the culmination of a process that involves complex cell division and maturation in the nucleus, cytoplasm and plasma membrane during spermiogenesis. Dysfunctions in spermiogenesis lead to the production of morphologically or functionally abnormal spermatozoa. Teratozoospermia is a condition characterized by the presence of a large percentage of abnormally shaped sperm in the semen [<xref ref-type="bibr" rid="scirp.128359-ref24">24</xref>] . Human spermatozoa have a high percentage of morphological abnormalities [<xref ref-type="bibr" rid="scirp.128359-ref11">11</xref>] . Sperm morphology is important in the assessment of male fertility. Abnormal sperm morphology can be accompanied by sperm DNA damage [<xref ref-type="bibr" rid="scirp.128359-ref25">25</xref>] . The combination of many sperm abnormalities significantly impairs its fertilizing power. This is the case of oligoasthenoteratozoospermia. Frikh et al. during their study of the prevalence of infertility in Rabat noted that oligoasthenoteratozoospermia is the most representative associated sperm pathology with 26.2% [<xref ref-type="bibr" rid="scirp.128359-ref26">26</xref>] .</p><p>Our results showed that semen pathologies such as azoospermia, oligoasthenoteratozoospermia are not associated with a variation in the enzymatic activity of glutathione peroxidase in seminal plasma. Indeed, the antioxidant activity of GPx was identical regardless of the values of the semen parameters. Our results are in agreement with those of Yeung et al. who showed that seminal plasma GPx enzymatic activity does not vary with semen quality [<xref ref-type="bibr" rid="scirp.128359-ref27">27</xref>] . Variation in GPx enzyme activity usually occurs when there is oxidative stress that results in an imbalance between pro-oxidants and antioxidants [<xref ref-type="bibr" rid="scirp.128359-ref28">28</xref>] . It is characterized by decreased motility, apoptosis, lipid peroxidation or DNA fragmentation of sperm [<xref ref-type="bibr" rid="scirp.128359-ref29">29</xref>] . Ammar et al. also showed that GPx enzymatic activity was reduced in sperm with varicocele-related oxidative stress [<xref ref-type="bibr" rid="scirp.128359-ref30">30</xref>] . This oxidative stress was evidenced by other parameters such as sperm DNA fragmentation, decreased enzymatic activity of superoxide dismutase and catalase, markers of lipid peroxidation [<xref ref-type="bibr" rid="scirp.128359-ref30">30</xref>] . Azoospermia may be associated with oxidative damage. Indeed, Le et al., showed that azoospermia induced by estradiol benzoate treatment in male mice was associated with oxidative stress [<xref ref-type="bibr" rid="scirp.128359-ref31">31</xref>] . Also subjects carrying heterozygous defects in the gene SECISBP2 have synthesis reduced of most of the 25 known human selenoproteins. They then present azoospermia, characterized by the failure of the last steps of spermatogenesis with a GPx deficiency [<xref ref-type="bibr" rid="scirp.128359-ref32">32</xref>] . Furthermore, the work of Sharma and Agarwal has shown that oxidative stress does not involve one compound or chemical reaction but a set of production and protection systems [<xref ref-type="bibr" rid="scirp.128359-ref33">33</xref>] . Currently, there is no recognized index or marker of oxidative stress. This is why a large number of indicators are used in order to obtain a set of presumptions concerning the importance of oxidative stress or the capacities organism’s defense. Therefore, this study does not allow us to establish a relationship between GPx enzymatic activity in seminal plasma and the sperm pathologies azoospermia and oligoasthenoteratozoospermia. In addition, numerous studies have suggested that decreased antioxidant levels in seminal plasma may be a potential cause of infertility [<xref ref-type="bibr" rid="scirp.128359-ref34">34</xref>] .</p><p>In oligoasthenosperms, Atig et al. showed that GPx enzyme activity was low compared to normozoosperms in contrast to our study which showed no significant difference between these two categories of semen [<xref ref-type="bibr" rid="scirp.128359-ref34">34</xref>] . Chyra-Jach et al. report GPx activities higher in seminal plasma of men with oligospermia and oligoasthenospermia [<xref ref-type="bibr" rid="scirp.128359-ref35">35</xref>] . While Garrido et al. indicate in their work that the enzymatic activity of GPx4 and GSH are correlated with the percentage of normal forms of spermatozoa in the semen. They conclude that GPx4 can be a biochemical marker of sperm maturation [<xref ref-type="bibr" rid="scirp.128359-ref36">36</xref>] . These results agree with Crisol et al. who showed a significant association of motility and morphological sperm parameters with GPx activity [<xref ref-type="bibr" rid="scirp.128359-ref37">37</xref>] . In contrast, Yeung et al. indicate that there was no correlation between GPx enzyme activity with morphology and the percentage of motile sperm in semen [<xref ref-type="bibr" rid="scirp.128359-ref27">27</xref>] . Nevertheless, it is important to note that GPx supplementation of semen improves sperm parameters when the latter has been affected by oxidative stress [<xref ref-type="bibr" rid="scirp.128359-ref38">38</xref>] .</p></sec><sec id="s5"><title>5. Conclusion</title><p>This study demonstrated the presence of glutathione peroxidase in the seminal plasma of normozoospermic, oligoasthenoteratozoospermic and azoospermic semen. It showed that the enzymatic activity of glutathione peroxidase is not related to the quality of the sperm. Enzymatic activity of glutathione peroxidase in seminal plasma is only related to oxidative stress. In order to better appreciate the activity of glutathione peroxidase in seminal plasma, it would be interesting to associate the enzyme activity with those of glutathione reductase (GR), superoxide dismutase (SOD) and catalase (CAT), which are the main enzymes involved in the metabolism of glutathione peroxidase.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The author declares no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>N’Guessan, M.F., Sery, B.B., Bi, F.J.V., Ekissi, N.A., Djohan, Y.F., Coulibaly, F.A. and Djaman, A.J. (2023) Evaluation of Glutathione Peroxidase Enzymatic Activity in Seminal Plasma of Patients Treated at the Institute Pasteur in Cote d’Ivoire. Advances in Reproductive Sciences, 11, 116-126. https://doi.org/10.4236/arsci.2023.114011</p></sec></body><back><ref-list><title>References</title><ref id="scirp.128359-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Mumbere, M.P., Muhindo, L., Juakali, S., Modia, O.A. and Katenga, B.G. (2021) Intérêt de la biochimie du plasma séminal dans l’exploration de l’infertilité masculine. Kisangani Medical, 11, 473-483.</mixed-citation></ref><ref id="scirp.128359-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Druart, X., Rickard, J.P., Tsikis, G. and de Graaf, S.P. (2019) Seminal Plasma Proteins as Markers of Sperm Fertility. Theriogenology, 137, 30-35.  
https://doi.org/10.1016/j.theriogenology.2019.05.034</mixed-citation></ref><ref id="scirp.128359-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Hofner, L., Luther, A.M. and Waberski, D. (2020) The Role of Seminal Plasma in the Liquid Storage of Spermatozoa. Animal Reproduction Science, 220, Article ID: 106290. https://doi.org/10.1016/j.anireprosci.2020.106290</mixed-citation></ref><ref id="scirp.128359-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Henkel, R.R. (2011) Leukocytes and Oxidative Stress: Dilemma for Sperm Function and Male Fertility. Asian Journal of Andrology, 13, 43-52.  
https://doi.org/10.1038/aja.2010.76</mixed-citation></ref><ref id="scirp.128359-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Oumaima, A., Tesnim, A., Zohra, H., Amira, S., Ines, Z., Sana, C., Intissar, G., Lobna, E., Ali, J. and Meriem, M. (2018) Investigation on the Origin of Sperm Morphological Defects: Oxidative Attacks, Chromatin Immaturity, and DNA Fragmentation. Environmental Science and Pollution Research, 25, 13775-13786.  
https://doi.org/10.1007/s11356-018-1417-4</mixed-citation></ref><ref id="scirp.128359-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Chabory, E., Damon, C., Lenoir, A., Henry-Berger, J., Vernet, P., Cadet, R., Saez, F. and Drevet, J.R. (2010) Mammalian Glutathione Peroxidases Control Acquisition and Maintenance of Spermatozoa Integrity. Journal of Animal Science, 88, 1321-1331.  
https://doi.org/10.2527/jas.2009-2583</mixed-citation></ref><ref id="scirp.128359-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Imai, H., Suzuki, K., Ishizaka, K., Ichinose, S., Oshima, H., Okayasu, I., Emoto, K., Umeda, M. and Nakagawa, Y. (2001) Failure of the Expression of Phospholipid Hydroperoxide Glutathione Peroxidase in the Spermatozoa of Human Infertile Males. Biology of Reproduction, 64, 674-683.  
https://doi.org/10.1095/biolreprod64.2.674</mixed-citation></ref><ref id="scirp.128359-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Drevet, J.R. (2006) The Antioxidant Glutathione Peroxidase Family and Spermatozoa: A Complex Story. Molecular and Cellular Endocrinology, 250, 70-79.  
https://doi.org/10.1016/j.mce.2005.12.027</mixed-citation></ref><ref id="scirp.128359-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Zhao, L., Zong, W., Zhang, H. and Liu, R. (2019) Kidney Toxicity and Response of Selenium Containing Protein-Glutathione Peroxidase (Gpx3) to CdTe QDs on Different Levels. Toxicological Sciences, 168, 201-208.v  
https://doi.org/10.1093/toxsci/kfy297</mixed-citation></ref><ref id="scirp.128359-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Pipolo, S., Puglisi, R., Mularoni, V., Esposito, V., Fuso, A., Lucarelli, M., Fiorenza, M.T., Mangia, F. and Boitani, C. (2018) Involvement of Sperm Acetylated Histones and the Nuclear Isoform of Glutathione Peroxidase 4 in Fertilization. Journal of Cellular Physiology, 233, 3093-3104. https://doi.org/10.1002/jcp.26146</mixed-citation></ref><ref id="scirp.128359-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Organisation Mondiale de la Santé (2021) Laboratory Manual for the Examination and Processing of Human Semen. 6ème éDition. WHO Press, Geneva.</mixed-citation></ref><ref id="scirp.128359-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Paglia, D.E. and Valentine, W.N. (1967) Studies on the Quantitative and Qualitative Characterization of Erythrocyte Glutathione Peroxidase. Journal of Laboratory and Clinical Medicine, 70, 158-169.</mixed-citation></ref><ref id="scirp.128359-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Almeida, S., Rato, L., Sousa, M., Alves, M.G. and Oliveira, P.F. (2017) Fertility and Sperm Quality in the Aging Male. Journal Current Pharmaceutical Design, 23, 4429- 4437. https://doi.org/10.2174/1381612823666170503150313</mixed-citation></ref><ref id="scirp.128359-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Stewart, A.F. and Kim, E.D. (2011) Fertility Concerns for the Aging Male. Urology, 78, 496-499. https://doi.org/10.1016/j.urology.2011.06.010</mixed-citation></ref><ref id="scirp.128359-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Sengupta, P. (2015) Reviewing Reports of Semen Volume and Male Aging of Last 33 Years: From 1980 through 2013. Asian Pacific Journal of Reproduction, 4, 242-246.  
https://doi.org/10.1016/j.apjr.2015.06.010</mixed-citation></ref><ref id="scirp.128359-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Batou, A.S., Abessolo, F.O., Mba, I. and Mintsa, A. (2018) Analyse des paramètres du spermogramme en relation avec le fructose, le citrate et l’alpha glucosidase neutre du sperme chez les hommes consultant pour infertilité à Libreville. International Journal of Biological and Chemical Sciences, 12, 2486-2502.  
https://doi.org/10.4314/ijbcs.v12i6.3</mixed-citation></ref><ref id="scirp.128359-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Auger, J. and Jouannet, P. (2005) Age and Male Fertility: Biological Factors. Revue d’épidémiologie et de Santé Publique, 53, 25-35.  
https://doi.org/10.1016/S0398-7620(05)84765-0</mixed-citation></ref><ref id="scirp.128359-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Robin, G., Marcelli, F., Mitchell, V., Marchetti, C., Lemaitre, L., Dewailly, D., Leroy- Billiard, M. and Rigot, J.M. (2008) Pourquoi et comment réaliser un bilan d’hypo- spermie? Gynécologie Obstétrique &amp; Fertilité, 36, 1035-1042.  
https://doi.org/10.1016/j.gyobfe.2008.04.021</mixed-citation></ref><ref id="scirp.128359-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">García-Vázquez, F.A., Gadea, J., Matás, C. and Holt, W.V. (2016) Importance of Sperm Morphology during Sperm Transport and Fertilization in Mammals. Asian Journal of Andrology, 18, 844-850. https://doi.org/10.4103/1008-682X.186880</mixed-citation></ref><ref id="scirp.128359-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Choy, J.T. and Amory, J.K. (2020) Nonsurgical Management of Oligozoospermia. Journal of Clinical Endocrinology and Metabolism, 105, e4194-e4207.  
https://doi.org/10.1210/clinem/dgaa390</mixed-citation></ref><ref id="scirp.128359-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Cocuzza, M., Alvarenga, C. and Pagani, R. (2013) The Epidemiology and Etiology of Azoospermia. Clinics, 68, 15-26. https://doi.org/10.6061/clinics/2013(Sup01)03</mixed-citation></ref><ref id="scirp.128359-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Forges, T., Monnier-Barbarino, P. and Foliguet, B. (2001) La vitalité des spermato- zoides. Andrologie, 11, 45-55. https://doi.org/10.1007/BF03034509</mixed-citation></ref><ref id="scirp.128359-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Shahrokhi, S.Z., Salehi, P., Alyasin, A., Taghiyar, S. and Deemeh, M.R. (2020) Asthenozoospermia: Cellular and Molecular Contributing Factors and Treatment Strategies. Andrologia, 52, e13463. https://doi.org/10.1111/and.13463</mixed-citation></ref><ref id="scirp.128359-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Rives, N. (2007) Tératozoospermie monomorphe et altérations nucléaires. Andrologie, 17, 341-342. https://doi.org/10.1007/BF03040369</mixed-citation></ref><ref id="scirp.128359-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Ammar, O., Mehdi, M. and Muratori, M. (2020) Teratozoospermia: Its Association with Sperm DNA Defects, Apoptotic Alterations, and Oxidative Stress. Andrology, 8, 1095-1106. https://doi.org/10.1111/andr.12778</mixed-citation></ref><ref id="scirp.128359-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Frikh, M., Benaissa, M., Kasouati, J., Benlahlou, Y., Chokairi, O., Barkiyou, M., Chadli, M., Maleb, A. and Elouennass, M. (2021) Prevalence de l’infertilité masculine dans un hopital universitaire au Maroc [Prevalence of Male Infertility in a University Hospital in Morocco]. Pan African Medical Journal, 38, Article 46.  
https://doi.org/10.11604/pamj.2021.38.46.19633</mixed-citation></ref><ref id="scirp.128359-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Yeung, C.H., Cooper, T.G., De Geyter, M., De Geyter, C., Rolf, C., Kamischke, A. and Nieschlag, E. (1998) Studies on the Origin of Redox Enzymes in Seminal Plasma and Their Relationship with Results of in-vitro Fertilization. Molecular Human Reproduction, 4, 835-839. https://doi.org/10.1093/molehr/4.9.835</mixed-citation></ref><ref id="scirp.128359-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Maiorino, M., Bosello, V., Ursini, F., Foresta, C., Garolla, A., Scapin, M., Sztajer, H. and Flohe, L. (2003) Genetic Variations of Gpx-4 and Male Infertility in Humans. Biology of Reproduction, 68, 1134-1141.  
https://doi.org/10.1095/biolreprod.102.007500</mixed-citation></ref><ref id="scirp.128359-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Noblanc, A., Kocer, A. and Drevet, J.R. (2012) Protection Post-Testiculaire des gamètes males contre les dommages radicalaires: Le role de l’épididyme [Post-Testicular Protection of Male Gamètes from Oxidative Damage. The Role of the Epididymis]. Médecine Sciences, 28, 519-525. https://doi.org/10.1051/medsci/2012285017</mixed-citation></ref><ref id="scirp.128359-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Ammar, O., Tekeya, O., Hannachi, I., Sallem, A., Haouas, Z. and Mehdi, M. (2021) Increased Sperm DNA Fragmentation in Infertile Men with Varicocele: Relationship with Apoptosis, Seminal Oxidative Stress, and Spermatic Parameters. Reproductive Sciences, 28, 909-919. https://doi.org/10.1007/s43032-020-00311-6</mixed-citation></ref><ref id="scirp.128359-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Le, J., Lei, X., Ren, Y., Li, Z., Tu, H., Ding, F., Yi, X., Zhou, Y., Liu, Q. and Zhang, S. (2019) Exogenous Oestradiol Benzoate Induces Male Mice Azoospermia through Modulation of Oxidative Stress and Testicular Metabolic Cooperation. Molecular Medecine Reports, 19, 4955-4963. https://doi.org/10.3892/mmr.2019.10169</mixed-citation></ref><ref id="scirp.128359-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Schoenmakers, E., Agostini, M., Mitchell, C., Schoenmakers, N., Papp, L., Rajanayagam, O., Padidela, R., Ceron-Gutierrez, L. and Chatterjee, K. (2010) Mutations in the Selenocysteine Insertion Sequence-Binding Protein 2 Gene Lead to a Multisystem Selenoprotein Deficiency Disorder in Humans. Journal of Clinical Investigation, 120, 4220-4235. https://doi.org/10.1172/JCI43653</mixed-citation></ref><ref id="scirp.128359-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Sharma, R.K. and Agarwal, A. (1996) Role of Reactive Oxygen Species in Male Infertility. Urology, 48, 835-850. https://doi.org/10.1016/S0090-4295(96)00313-5</mixed-citation></ref><ref id="scirp.128359-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Atig, F., Raffa, M., Ali, H.B., Abdelhamid, K., Saad, A. and Ajina, M. (2012) Altered Antioxidant Status and Increased Lipid Per-Oxidation in Seminal Plasma of Tunisian Infertile Men. International Journal Biological Sciences, 8, 139-149.  
https://doi.org/10.7150/ijbs.8.139</mixed-citation></ref><ref id="scirp.128359-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Chyra-Jach, D., Kaletka, Z., Dobrakowski, M., Machoń-Grecka, A., Kasperczyk, S., Birkner, E. and Kasperczyk, A. (2018) The Associations between Infertility and Antioxidants, Proinflammatory Cytokines, and Chemokines. Oxidative Medicine and Cellular Longevity, 2018, Article ID: 8354747.  
https://doi.org/10.1155/2018/8354747</mixed-citation></ref><ref id="scirp.128359-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Garrido, N., Meseguer, M., Alvarez, J., Simón, C., Pellicer, A. and Remohí, J. (2004) Relationship among Standard Semen Parameters, Glutathione Peroxidase/Glutathione Reductase Activity, and mRNA Expression and Reduced Glutathione Content in Ejaculated Spermatozoa from Fertile and Infertile Men. Fertility and Sterility, 82, 1059-1066. https://doi.org/10.1016/j.fertnstert.2004.04.033</mixed-citation></ref><ref id="scirp.128359-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">Crisol, L., Matorras, R., Aspichueta, F., Expósito, A., Hernández, M.L., Ruiz-Larrea, M.B., Mendoza, R. and Ruiz-Sanz, J.I. (2012) Glutathione Peroxidase Activity in Seminal Plasma and Its Relationship to Classical Sperm Parameters and in vitro Fertilization-Intracytoplasmic Sperm Injection Outcome. Fertility and Sterility, 97, 852-857.E1. https://doi.org/10.1016/j.fertnstert.2012.01.097</mixed-citation></ref><ref id="scirp.128359-ref38"><label>38</label><mixed-citation publication-type="other" xlink:type="simple">Del-Prete, C., Stout, T., Montagnaro, S., Pagnini, U., Uccello, M., Florio, P., Ciani, F., Tafuri, S., Palumbo, V., Pasolini, M.P., Cocchia, N. and Henning, H. (2019) Combined Addition of Superoxide Dismutase, Catalase and Glutathione Peroxidase Improves Quality of Cooled Stored Stallion Semen. Animal Reproduction Science, 210, 106-195. https://doi.org/10.1016/j.anireprosci.2019.106195</mixed-citation></ref></ref-list></back></article>